期刊文献+

c-src activating mutation analysis in Chinese patients with colorectal cancer

c-src activating mutation analysis in Chinese patients with colorectal cancer
下载PDF
导出
摘要 AIM: To investigate the occurrence of cellular src (c-src)activating mutation at codon 531 in colorectal cancer patients from Chinese mainland.METHODS: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay followed by sequencing and single-strand conformation polymorphism analysis were carried out to screen 110 samples of primary colorectal cancer and 20 colorectal liver metastases.RESULTS: Only one sample showed PCR-RFLP-positive results and carried somatic codon 531 mutations. No additional mutation of c-src exon 12 was found.CONCLUSION: c-src codon 531 mutation in colorectal cancer is not the cause of c-src activation. AIM:To investigate the occurrence of cellular src (c-src) activating mutation at codon 531 in colorectal cancer patients from Chinese mainland. METHODS: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay followed by sequencing and single-strand conformation polymorphism analysis were carried out to screen 110 samples of primary colorectal cancer and 20 colorectal liver metastases. RESULTS: Only one sample showed PCR-RFLP-positive results and carried somatic codon 531 mutations. No additional mutation of c-src exon 12 was found. CONCLUSION: c-srccodon 531 mutation in colorectal cancer is not the cause of c-srcactivation.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第15期2351-2353,共3页 世界胃肠病学杂志(英文版)
基金 Supported by the Major State Basic Research Development Program of China, No. G1998051210
关键词 C-SRC 基因突变 中国 结肠肿瘤 直肠肿瘤 c-src Colorectal cancer
  • 相关文献

参考文献18

  • 1Yeatman TJ. A renaissance for SRC. Nat Rev Cancer 2004; 4:470-480.
  • 2Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ. Activating src mutation in a subset of advanced human colon cancers. Nature genetics 1999; 21:187-191.
  • 3Daigo Y, Furukawa Y, Kawasoe T, Ishiguro H, Fujita M,Sugai S, Nakamori S, Liefers GJ, Tollenaar RA, van de Velde CJ, Nakamura Y. Absence of genetic alteration at codon 531 of the human c-src gene in 479 advanced colorectal cancers from Japanese and Caucasian patients. Cancer Res 1999; 59:4222-4224.
  • 4Nilbert M, Fernebro E. Lack of activating c-src mutations at codon 531 in rectal cancer. Cancer Genet Cytogenet 2000; 121:94-95.
  • 5Wang NM, Yeh KT, Tsai CH, Chen SJ, Chang JG. No evidence of correlation between mutation at codon 531 of src and the risk of colon cancer in Chinese. Cancer Lett 2000; 150:201-204.
  • 6Laghi L, Bianchi P, Orbetegli O, Gennari L, Roncalli M, Malesci A. Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients. Br J Cancer 2001; 84:196-198.
  • 7Blin N, Stafford DW.A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976; 3:2303-2308.
  • 8Ho $N, Hunt HD, Horton RM, Pullen JK, Pease LR. Sitedirected mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989; 77:51-59.
  • 9Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5:874-879.
  • 10Warmuth M, Damoiseaux R, Liu Y, Fabbro D, Gray N. SRC family kinases: potential targets for the treatment of human cancer and leukemia. Curr Pharm Des 2003; 9:2043-2059.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部